Andere Sprachen Mankind Pharma Limited

Aktien

A3EFQV

INE634S01028

MANKIND

Markt geschlossen - NSE India S.E. Andere Börsenplätze 13:43:52 17.05.2024			% 5 Tage	% 1. Jan.
2.091 ^INR	-0,09 %		-6,53 %	+5,46 %

16.05.	Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024
16.05.	Mankind Pharmas konsolidierter Gewinn springt im vierten Quartal des Geschäftsjahres	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4	16.05.
India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment	15.05.
Mankind Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	15.05.
India's weight in key MSCI equity index hits another high, to boost inflows	15.05.
Mankind Pharma Reportedly in Fray to Acquire Advent's Stake in Bharat Serums	14.05.
Mankind Pharma Limited Receives Order from Office of the Assistant Commissioner of Central Tax, Ballygunge Division Kolkata	09.05.
KKR, Novo Nordisk, Others Reportedly Bid for Healthium Buy	03.05.
Mankind Pharma Limited Receives Order from Office of Commissioner of Central Tax, Central Excise and Service Tax, Secunderabad GST Commissionerate GST Bhawan, Hyderabad	26.04.
CARE Gives AA+ Rating to Mankind Pharma's Long-term Bank Financing; Outlook Stable	26.04.
Mankind Pharma to Sell its Over the Counter Business on Slump Sale Basis	04.04.
Mankind Pharma to Sell OTC Business to Wholly-Owned Subsidiary	03.04.
Mankind Pharma to Form New Subsidiary for Consumer Healthcare Products	02.04.
Mankind Pharma Limited Announces Incorporation of Wholly Owned Subsidiary Mankind Consumer Products Private Limited	02.04.
Mankind Reportedly Joins Race for Healthium Medtech	29.03.
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	11.03.
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	11.03.
India's Jubilant Pharmova posts quarterly profit	02.02.
Mankind Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit; Shares Rise 3%	01.02.
India's Mankind Pharma beats Q3 profit estimates on strong demand	31.01.
Mankind Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Mankind Pharma Limited

Aktien

A3EFQV

INE634S01028

MANKIND

Andere Sprachen

Filter